InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,070.51
(
1.20%
)
US TECH 100
17,022.80
(
1.61%
)
Dow Jones
38,499.60
(
0.68%
)
Brent Oil
87.54
(
1.30%
)
Bitcoin
66,530.52
(
-0.49%
)
Post# of 251571
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: poorgradstudent post# 208207

Thursday, 01/19/2017 1:33:40 PM

Thursday, January 19, 2017 1:33:40 PM

Post# of 251571

The cancer reproducibility project is trying to reproduce select papers. The pivotal one from Weissman appears to have ran into some trouble.

Are you suggesting there are concerns now about the viability of targeting SIRP-CD47 in general? Would just add that, beyond Weissman, there are several others now (CELG, TRIL, etc.) that now have independent pre-clinical support of their own for this approach. Sure, this still needs to all be proven in the clinic (and explains why TRIL is still in the doldrums).
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up